BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33568988)

  • 1. Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers.
    Ma LY; Tian Y; Pan CR; Chen ZL; Ling Y; Ren K; Li JS; Feng T
    Front Aging Neurosci; 2020; 12():627199. PubMed ID: 33568988
    [No Abstract]   [Full Text] [Related]  

  • 2. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A progression analysis of motor features in Parkinson's disease based on the mapper algorithm.
    Ma LY; Feng T; He C; Li M; Ren K; Tu J
    Front Aging Neurosci; 2023; 15():1047017. PubMed ID: 36896420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson's Disease Patients.
    Solla P; Wang Q; Frau C; Floris V; Loy F; Sechi LA; Masala C
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF Aβ
    Ba M; Yu G; Kong M; Liang H; Yu L
    Transl Neurodegener; 2018; 7():22. PubMed ID: 30338062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.
    Chahine LM; Siderowf A; Barnes J; Seedorff N; Caspell-Garcia C; Simuni T; Coffey CS; Galasko D; Mollenhauer B; Arnedo V; Daegele N; Frasier M; Tanner C; Kieburtz K; Marek K;
    J Parkinsons Dis; 2019; 9(4):665-679. PubMed ID: 31450510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease.
    Otaiku AI
    Mov Disord Clin Pract; 2021 Oct; 8(7):1041-1051. PubMed ID: 34631940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.
    Tsiouris KM; Konitsiotis S; Koutsouris DD; Fotiadis DI
    Artif Intell Med; 2020 Mar; 103():101807. PubMed ID: 32143804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
    Simuni T; Caspell-Garcia C; Coffey CS; Weintraub D; Mollenhauer B; Lasch S; Tanner CM; Jennings D; Kieburtz K; Chahine LM; Marek K
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):78-88. PubMed ID: 28986467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression.
    Chen Y; Xue NJ; Fang Y; Jin CY; Li YL; Tian J; Yan YP; Yin XZ; Zhang BR; Pu JL
    Mov Disord Clin Pract; 2022 Oct; 9(7):909-919. PubMed ID: 36247907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of cognitive impairment in newly diagnosed Parkinson's disease with normal cognition at baseline: A 5-year cohort study.
    Chen J; Zhao D; Wang Q; Chen J; Bai C; Li Y; Guo X; Chen B; Zhang L; Yuan J
    Front Aging Neurosci; 2023; 15():1142558. PubMed ID: 36926634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression.
    Dou K; Ma J; Zhang X; Shi W; Tao M; Xie A
    Front Aging Neurosci; 2022; 14():977985. PubMed ID: 36092799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images.
    Adams MP; Rahmim A; Tang J
    Comput Biol Med; 2021 May; 132():104312. PubMed ID: 33892414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.
    Sanjari Moghaddam H; Valitabar Z; Ashraf-Ganjouei A; Mojtahed Zadeh M; Ghazi Sherbaf F; Aarabi MH
    Neuromolecular Med; 2018 Sep; 20(3):376-385. PubMed ID: 29980980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the progression of Parkinson's disease using conventional MRI and machine learning: An application of radiomic biomarkers in whole-brain white matter.
    Shu ZY; Cui SJ; Wu X; Xu Y; Huang P; Pang PP; Zhang M
    Magn Reson Med; 2021 Mar; 85(3):1611-1624. PubMed ID: 33017475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson's symptoms, rapid eye movement sleep disorder, and neuropsychological profile.
    Byeon H
    World J Psychiatry; 2020 Nov; 10(11):245-259. PubMed ID: 33269221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.